Systemic sclerosis-associated interstitial lung disease (SSc-ILD) is a serious complication affecting up to half of people with scleroderma, and it’s a leading cause of death. New guidelines and ...
Patients with interstitial lung disease who are positive for anti-Ku antibody may show progressive fibrotic behavior.